Dr. Rakesh K Srivastava

Research Discovers Potential New Rx Target for Colon Cancer

Research discovers potential new Rx target for colon cancer

SATB2 is a novel “transcription factor” – a protein “switch” that controls which genes are turned on or off inside a cancer cell. Drs. Rakesh Srivastava and Sharmila Shankar identified it in the so-called “cancer stem cells” – cancer cells that behave like stem cells. Cancer stem cells are a small subset of immortal cells in tumors that […]